GSK joins UK China trade push

 21-Oct-15, Reuters

GlaxoSmithKline's (GSK.L) chief executive is joining a new panel to promote trade between Britain and China, just over a year after the drugmaker was handed a record fine of nearly $500 million (323 million pounds) for bribing Chinese doctors.

Image: Reuters / Luke Macgregor

The group has since been rebuilding its position in China.

The move came as Britain announced the signing of more than 2 billion pounds ($3.1 billion) of healthcare trade deals between Chinese and UK companies, universities and organisations during President Xi Jinping's visit to Britain.

 Read the full article  

 Insights